Serious viral diseases: significant threats

Myxomatosis and rabbit hemorrhagic disease (RHD) are two viral diseases of major clinical significance in rabbits¹. These serious and widespread diseases put all rabbits at risk of high morbidity and mortality. More recently with the emergence a new variant form of RHD, the threat to your patients needs a more comprehensive answer.

Myxomatosis

Myxomatosis is a serious and widespread viral disease of both wild and domestic rabbits that is typically fatal once contracted. It is one of the top 8 causes of death in UK pet rabbits.

In its classic form it is a highly distressing disease which cannot be successfully treated, however vaccination is very effective at reducing the risk of disease.

Rabbit Hemorrhagic Disease

A highly infectious and widespread disease caused by a calicivirus and often resulting in swift and sudden death³.

Until recently, this disease was caused by ‘classic’ strains of RHD virus (RHDV-1) and effective vaccines were available. In 2010, a new pathogenic variant RHD virus was reported to be causing severe disease in Europe, against which the classic strain vaccines were much less effective. This variant strain (RHDV-2) has since spread throughout Europe and is causing disease in both wild and pet rabbits^3-5.

For comprehensive protection a vaccine needs to demonstrate efficacy against both forms of RHD.

Nobivac^® Myxo-RHD PLUS contains live myxoma vectored RHD virus strain 009 and MK 1898. POM-V
MSD Animal Health UK Limited. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942.
Further information is available from the SPC, Datasheet or package leaflet. Advice should be sought from the medicine prescriber.
Use medicines responsibly